Cortes JE, Kantarjian HM, Brümmendorf TH, et al. Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib. Blood. 2011;118(17):4567-4576.

Zdroj:	In Blood 3 October 2013 122(14):2524-2524
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu